AGT and heart disorder: Historically, caution has been taken when prescribing spironolactone without additional RAAS modulating drugs such as ACE-I or ARBs in patients with heart disease due to concern for upregulation of upstream RAAS metabolites associated with negative cardiovascular effects, such as AngII.